Fidelity Advisor Biotechnology Fund Class A (FBTAX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 0 |
| Enterprise Value | 13.68M |
| P/E Ratio | 13.52 |
| PEG Ratio | 0.93 |
| Price/Sales Ratio | 5 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 5.03 |
| Enterprise/EBITDA | 30.63 |
Fiscal Year
| Fiscal Year | February 03, 2024 |
| Most Recent Quarter | February 03, 2024 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.14 |
AD
Management Effectiveness
| Return On Assets | 0.19 |
| Return On Equity | 0.42 |
Income Statement
| Revenue | 486.11M |
| Revenue/Share | 0 |
| Gross Profit | 264.99M |
| EBITDA | 79.76M |
| Net Income | 52.81M |
| Diluted EPS | 3.65 |
Balance Sheet
| Total Cash | 43.93M |
| Total Cash/Share | 0 |
| Total Debt | 57.61M |
| Total Debt/Equity | 0.44 |
| Current Ratio | 1.53 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | 32.38 |
| 52-Week High | 52.27 |
| 52-Week Low | 36.07 |
| Moving Average 50 Days | 47.22 |
| Moving Average 200 Days | 42.78 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 49.23M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.54 |
| Trailing Annual Dividend Yield | 1.1 |
| Payout Ratio | 0.42 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
